- Home
- TRAK vs VRCA Comparison
TRAK vs VRCA Comparison
Compare TRAK & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAK
- VRCA
- Stock Information
- Founded
- TRAK 1990
- VRCA 2013
- Country
- TRAK United States
- VRCA United States
- Employees
- TRAK N/A
- VRCA N/A
- Industry
- TRAK EDP Services
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- TRAK Technology
- VRCA Health Care
- Exchange
- TRAK Nasdaq
- VRCA Nasdaq
- Market Cap
- TRAK 351.4M
- VRCA 363.1M
- IPO Year
- TRAK 1998
- VRCA 2018
- Fundamental
- Price
- TRAK $20.58
- VRCA $0.80
- Analyst Decision
- TRAK Strong Buy
- VRCA Buy
- Analyst Count
- TRAK 1
- VRCA 6
- Target Price
- TRAK $24.00
- VRCA $7.33
- AVG Volume (30 Days)
- TRAK 41.1K
- VRCA 646.5K
- Earning Date
- TRAK 11-14-2024
- VRCA 11-04-2024
- Dividend Yield
- TRAK 0.32%
- VRCA N/A
- EPS Growth
- TRAK 7.41
- VRCA N/A
- EPS
- TRAK 0.29
- VRCA N/A
- Revenue
- TRAK $20,453,320.00
- VRCA $9,210,000.00
- Revenue This Year
- TRAK $14.70
- VRCA $291.12
- Revenue Next Year
- TRAK $15.00
- VRCA $104.31
- P/E Ratio
- TRAK $71.74
- VRCA N/A
- Revenue Growth
- TRAK 7.09
- VRCA 187.45
- 52 Week Low
- TRAK $8.94
- VRCA $0.70
- 52 Week High
- TRAK $21.56
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- TRAK 64.95
- VRCA 26.09
- Support Level
- TRAK $18.55
- VRCA $1.40
- Resistance Level
- TRAK $19.61
- VRCA $1.74
- Average True Range (ATR)
- TRAK 0.58
- VRCA 0.13
- MACD
- TRAK 0.10
- VRCA -0.06
- Stochastic Oscillator
- TRAK 84.43
- VRCA 0.00
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.